Galenica Rg
GALE
CHF
STOCK MARKET:
SWX
Closed
 
...
Large gap with delayed quotes
Last quote
01/06/2025 - 17:31:17
Bid
01/06/2025 - 17:19:55
Bid
Volume
Ask
01/06/2025 - 17:48:37
Ask
Volume
75.70
+0.65 ( +0.87% )
75.55
204
0.00
100
More information
Analysis by TheScreener
03.01.2025
Evaluation Slightly negative  
Interest Very weak  
Sensibility Middle  
Analysis date: 03.01.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 03.01.2025.
Interest
  Very weak
Very weak interest since 03.01.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.01.2025 at a price of 75.05.
Evaluation
  Neutral
 
Based on its growth potential and our own criteria, at its current price the stock is fairly valued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 17.12.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is .
4wk Rel Perf
  -0.60%
 
The four week relative performance versus STOXX600 is .
Sensibility
  Middle
The stock has been on the moderate-sensitivity level since 06.08.2024.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.22%.
Mkt Cap in $bn
  4.09
With a market capitalization between $2 & $8bn, GALENICA SANTE is considered a mid-cap stock.
G/PE Ratio
  0.82
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  19.65
The estimated PE is for the year 2026.
LT Growth
  12.94%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
  3.09%
The twelve month estimated dividend yield represents 60.61% of earnings forecasts.
Beta
  52
For 1% of index variation, the stock varies on average by 0.52%.
Correlation
  0.39
Stock movements are strongly independent of index variations.
Value at Risk
  9.01
The value at risk is estimated at CHF 9.01. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  11.08.2017